Following disappointing rate increases in the Medicare segment that triggered a sector‐wide selloff, CVS Health has emerged as one of the best‐prepared operators. The company’s early restructuring efforts, which included reducing its exposure to high‐risk government programs and implementing broad cost‐cutting measures last year, have helped protect operating margins. Management’s initiatives to streamline pharmacy benefit management operations and integrate in-store clinic services have cushioned the impact of reimbursement pressures. With consensus forecasts embedding low‐single‐digit revenue growth and forward earnings multiples in the 10–11x range—well below peer averages—CVS is trading at a material discount that could narrow if execution remains on track.

In the most recent regulatory filings, Strengthening Families & Communities LLC boosted its stake in CVS by 1,923.9%, purchasing 30,090 additional shares to bring its total to 31,654 shares. This dramatic increase highlights growing confidence among specialized asset managers in CVS’s ability to navigate current headwinds. Other institutions followed suit: QRG Capital Management added nearly 59,000 shares during the second quarter, representing a 173.9% increase, while Hilltop National Bank established a new position in the same period. Overall, more than 80% of CVS’s outstanding shares remain in institutional hands, underscoring the market’s view that recent stock weakness offers an attractive entry point.